American Society for Nephrology (ASN) Kidney Week: Nov 5-10, 2019; Washington, D.C. 

A big focus on alkaline phosphatase. Three presentations on the schedule for next couple of days. 

November 8th: 1048: Apabetalone Lowers Serum Alkaline Phosphatase in CVD Patients with and Without CKD and Improves Cardiovascular Risk

November 8th: 317: Association of Serum Alkaline Phosphatase with CKD and Cognitive Function in Patients with Diabetes and Acute Coronary Syndrome

November 9th: 782: Apabetalone Downregulates Alkaline Phosphatase and Improves Cardiovascular Risk

Correct me if I'm wrong but Resverlogix hasn't news released, tweeted, listed in their fact sheet events, or mentioned in recent webcasts anything about this conference. 

BearDownAZ